Antimicrobials News

Diabetes, first described in ancient Egypt, remains at the forefront of health care in modern times. Roughly 537 million adults aged 20 to 79 years are living with diabetes worldwide, a number expected to rise over the next decades.

“Soap, water and common sense are the best disinfectants.” - William Osler.

Liver transplant recipients with daptomycin-resistant Enterococcus bacteremia were more than twice as likely to die within a year compared with those who had vancomycin-resistant Enterococcus bacteremia, a study found.

Oral ibrexafungerp demonstrated a sustained advantage over placebo in the prevention of recurrent vulvovaginal candidiasis in a phase 3 trial, Scynexis announced Thursday.

Five-year follow-up data from the POET trial continued to demonstrate the usefulness of oral antibiotics for left-sided endocarditis, with no indications of long-term treatment failure among participants, researchers reported.

Periods of high influenza activity in the United States seem to correspond with high rates of antibiotic resistance in both respiratory and nonrespiratory infections, researchers found.

A trial that evaluated three alternative treatments for anogenital gonorrhea found that a single dose of ertapenem was 99% effective — on par with ceftriaxone, which is recommended as first-line therapy.

Oral penicillin may be safer than the injectable option for people with rheumatic heart disease who are at high risk for a cardiac reaction, according to a new American Heart Association presidential advisory.

Antibiotic-resistant infections, on the rise globally, killed more than 1.2 million people in 2019, according to a new estimate published recently in The Lancet.

New guidelines issued in 2021 stated a preference for fidaxomicin as first-line treatment for Clostridioides difficile infection, despite concerns about its cost.